Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$11.26M |
|
$1.97M |
|
$9.19M |
|
$18.89M |
|
$6.43M |
|
$0.15M |
|
$1.82M |
|
$8.25M |
|
$10.63M |
|
$3.42M |
|
$10.63M |
|
-- |
|
| Cash Flow Statement Financials | |
$-15.67M |
|
$-0.76M |
|
$10.94M |
|
$7.63M |
|
$2.13M |
|
$-5.50M |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|